Linlin Ma

Dr. Linlin Ma is a Senior Lecturer at Griffith University's School of Environment and Science (Bioscience program). She holds affiliations with the Institute for Biomedicine and Glycomics and the Griffith Institute for Drug Discovery. Her research focuses on ion channel dysfunction in neurodegenerative diseases, particularly Parkinson's disease, using techniques like electrophysiology and CRISPR-based models. She has supervised over 20 doctoral and master's students and teaches courses in pharmacology and biomolecular science.

Education: PhD in Pharmacy and Biomedical Sciences (University of South Australia), MSc in Medical Genetics (Harbin Medical University), and a Bachelor of Medicine (Harbin Medical University). She also holds a Graduate Certificate in Higher Education from The University of Queensland.

Research Interests: Ion channel biology, neurodegeneration mechanisms, drug discovery from natural products, and mitochondrial dysfunction. Key projects include identifying Kir4.2 channel modifiers for Parkinson's treatment and exploring sea anemone peptides for anticancer activity.

Funding: Secured grants from NHMRC, Michael J Fox Foundation, and industry partners like Hainan Medical University. Active in grant management for equipment like electrophysiology setups and calcium imaging systems.

Awards: GRIDD Excellence in Teamwork Award (2021), Head of School Teaching Commendation (2020, 2019).

Leadership: Program Director for Griffith's Biomolecular Science programs. Editor roles for Frontiers journals in Pharmacology and Physiology, and conference organizing roles for the Australian Physiological Society.